FDA Approves First Customizable Insulin Pump

FRIDAY, Feb. 15, 2019 -- The Tandem Diabetes Care t:Slim X2 insulin pump, which allows a patient to customize treatment, has been approved by the U.S. Food and Drug Administration.
The new device is described as either an alternate controller...

Source: Drugs.com - Pharma News - February 15, 2019 Category: Pharmaceuticals Source Type: news